| P2093 | author name string | Oystein Bruserud | |
| | Elisabeth Ersvaer | |
| | Håkon Reikvam | |
| | Kimberley J Hatfield | |
| P2860 | cites work | Physical interaction of Delta1, Jagged1, and Jagged2 with Notch1 and Notch3 receptors | Q24290323 |
| | The notch ligand jagged-1 represents a novel growth factor of human hematopoietic stem cells | Q24290490 |
| | TAN-1, the human homolog of the Drosophila Notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms | Q24320364 |
| | Molecular genetic characterization of six recessive viable alleles of the mouse agouti locus | Q24533165 |
| | Binding of Delta1, Jagged1, and Jagged2 to Notch2 rapidly induces cleavage, nuclear translocation, and hyperphosphorylation of Notch2 | Q24550771 |
| | Direct inhibition of the NOTCH transcription factor complex | Q24634015 |
| | Therapeutic antibody targeting of individual Notch receptors | Q27660544 |
| | Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement | Q27861120 |
| | Genetic interaction of PGE2 and Wnt signaling regulates developmental specification of stem cells and regeneration | Q28238880 |
| | A carboxy-terminal deletion mutant of Notch1 accelerates lymphoid oncogenesis in E2A-PBX1 transgenic mice | Q43457473 |
| | Nutlin-3 up-regulates the expression of Notch1 in both myeloid and lymphoid leukemic cells, as part of a negative feedback antiapoptotic mechanism | Q43607424 |
| | Dendritic cell recovery after allogeneic stem-cell transplantation in acute leukemia: correlations with clinical and transplant characteristics | Q44077298 |
| | Expression of activated Notch3 in transgenic mice enhances generation of T regulatory cells and protects against experimental autoimmune diabetes | Q44625248 |
| | Cotransplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation | Q44746492 |
| | Jagged1-dependent Notch signaling is dispensable for hematopoietic stem cell self-renewal and differentiation. | Q45154679 |
| | Notch2 integrates signaling by the transcription factors RBP-J and CREB1 to promote T cell cytotoxicity. | Q45345853 |
| | Overexpression of the Notch ligand, Jagged-1, induces alloantigen-specific human regulatory T cells | Q45863413 |
| | Clinical relevance of NK, NKT, and dendritic cell dose in patients receiving G-CSF-mobilized peripheral blood allogeneic stem cell transplantation. | Q46823521 |
| | Hey2 acts upstream of Notch in hematopoietic stem cell specification in zebrafish embryos | Q47073951 |
| | Instruction of distinct CD4 T helper cell fates by different notch ligands on antigen-presenting cells | Q47619638 |
| | Viral disease prevention after hematopoietic cell transplantation | Q47627052 |
| | Successful immune reconstitution decreases leukemic relapse and improves survival in recipients of unrelated cord blood transplantation. | Q51790047 |
| | Prognostically useful gene-expression profiles in acute myeloid leukemia. | Q51999490 |
| | Rapid immunologic reconstitution following transplantation with mobilized peripheral blood stem cells as compared to bone marrow. | Q52044336 |
| | Down-regulation of Notch-1 expression decreases PU.1-mediated myeloid differentiation signaling in acute myeloid leukemia. | Q52587062 |
| | Cutting edge: Plasmacytoid dendritic cells induce IL-10 production in T cells via the Delta-like-4/Notch axis. | Q52906696 |
| | Activating NOTCH1 mutations predict favorable early treatment response and long-term outcome in childhood precursor T-cell lymphoblastic leukemia. | Q52933515 |
| | Regulation of mesenchymal stem cell activity by endothelial cells. | Q54424874 |
| | Expression analysis of Notch-related molecules in peripheral blood T helper cells of patients with rheumatoid arthritis. | Q54442995 |
| | NOTCH1 mutations are rare in acute myeloid leukemia. | Q54571392 |
| | Diverse effects of the Notch ligands Jagged1 and Delta1 on the growth and differentiation of primary acute myeloblastic leukemia cells. | Q54668113 |
| | Acute lymphoblastic leukaemia | Q56722375 |
| | Fungal infection prevention after hematopoietic cell transplantation | Q56970496 |
| | Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin lymphoma | Q60976795 |
| | Toll-Like Receptors 3 and 4 Are Expressed by Human Bone Marrow-Derived Mesenchymal Stem Cells and Can Inhibit Their T-Cell Modulatory Activity by Impairing Notch Signaling | Q61638150 |
| | Serrate1-induced notch signalling regulates the decision between immunity and tolerance made by peripheral CD4(+) T cells | Q73399528 |
| | Recovery of lymphocyte and dendritic cell subsets after autologous CD34+ cell transplantation | Q73934560 |
| | Notch-1 regulates NF-kappaB activity in hemopoietic progenitor cells | Q74601849 |
| | Autografting of highly purified peripheral blood progenitor cells following myeloablative therapy in patients with lymphoma: a prospective study of the long-term effects on tumor eradication, reconstitution of hematopoiesis and immune recovery | Q78151865 |
| | Itch genetically interacts with Notch1 in a mouse autoimmune disease model | Q79344563 |
| | Deregulation and cross talk among Sonic hedgehog, Wnt, Hox and Notch signaling in chronic myeloid leukemia progression | Q79954750 |
| | Kinetics of recovery of dendritic cell subsets after reduced-intensity conditioning allogeneic stem cell transplantation and clinical outcome | Q80138570 |
| | Modulation of Notch signaling by antibodies specific for the extracellular negative regulatory region of NOTCH3 | Q80465114 |
| | Notch3 inhibition in myelin-reactive T cells down-regulates protein kinase C theta and attenuates experimental autoimmune encephalomyelitis | Q80633672 |
| | Integration of Notch and Wnt signaling in hematopoietic stem cell maintenance | Q81308407 |
| | JAGGED1 and delta1 differentially regulate the outcome of experimental autoimmune encephalomyelitis | Q81464305 |
| | Defects in Notch1 upregulation upon activation of T Cells from patients with systemic lupus erythematosus are related to lupus disease activity | Q81638108 |
| | Constitutively activated Notch signaling is involved in survival and apoptosis resistance of B-CLL cells | Q81974229 |
| | Early pre-engraftment, functional, in vitro responsiveness of T lymphocytes in allotransplanted, acute leukemia patients: proliferation and release of a broad profile of cytokines, possibly predictive of graft-versus-host disease | Q82856669 |
| | Notch signaling in the immune system | Q82881379 |
| | Rapid helper T-cell recovery above 200 x 10 6/l at 3 months correlates to successful transplant outcomes after allogeneic stem cell transplantation | Q83339301 |
| | Immunological reconstitution after hematopoietic cell transplantation - its relation to the contents of the graft | Q94696821 |
| | Targeted therapy in acute myeloid leukaemia: current status and future directions | Q94863269 |
| | Inhibitors of gamma-secretase block in vivo and in vitro T helper type 1 polarization by preventing Notch upregulation of Tbx21 | Q95814547 |
| | Regulation of T cell activation by Notch ligand, DLL4, promotes IL-17 production and Rorc activation | Q95816367 |
| | Non-canonical activation of Notch signaling/target genes in vertebrates. | Q37748565 |
| | Targeting Notch to target cancer stem cells. | Q37763414 |
| | Translocation products in acute myeloid leukemia activate the Wnt signaling pathway in hematopoietic cells. | Q38343552 |
| | Perturbation of Ikaros isoform selection by MLV integration is a cooperative event in Notch(IC)-induced T cell leukemogenesis | Q38352939 |
| | Glycogen synthase kinase-3 is an in vivo regulator of hematopoietic stem cell repopulation | Q38511921 |
| | Notch2 signaling is required for potent antitumor immunity in vivo. | Q39721274 |
| | Notch signaling maintains proliferation and survival of the HL60 human promyelocytic leukemia cell line and promotes the phosphorylation of the Rb protein | Q39739099 |
| | Thymic development beyond beta-selection requires phosphatidylinositol 3-kinase activation by CXCR4. | Q39758257 |
| | DLL4 blockade inhibits tumor growth and reduces tumor-initiating cell frequency | Q39815141 |
| | Notch signaling: a novel regulating differentiation mechanism of human umbilical cord blood-derived mesenchymal stem cells into insulin-producing cells in vitro. | Q39885789 |
| | Induction of antigen-specific regulatory T cells following overexpression of a Notch ligand by human B lymphocytes | Q39997530 |
| | The proteasome inhibitors bortezomib and PR-171 have antiproliferative and proapoptotic effects on primary human acute myeloid leukaemia cells | Q40162776 |
| | Subclassification of patients with acute myelogenous leukemia based on chemokine responsiveness and constitutive chemokine release by their leukemic cells | Q40163161 |
| | Activating mutations in NOTCH1 in acute myeloid leukemia and lineage switch leukemias. | Q40226175 |
| | CUTLL1, a novel human T-cell lymphoma cell line with t(7;9) rearrangement, aberrant NOTCH1 activation and high sensitivity to gamma-secretase inhibitors | Q40281359 |
| | Expression of Notch1 and Jagged1 proteins in acute myeloid leukemia cells | Q40769746 |
| | Wnt signaling regulates hemopoiesis through stromal cells. | Q40794241 |
| | Jagged2-expressing hematopoietic progenitors promote regulatory T cell expansion in the periphery through notch signaling | Q42602502 |
| | Notch versus the proteasome: what is the target of gamma-secretase inhibitor-I? | Q42957812 |
| | Targeting the angiopoietin (Ang)/Tie-2 pathway in the crosstalk between acute myeloid leukaemia and endothelial cells: studies of Tie-2 blocking antibodies, exogenous Ang-2 and inhibition of constitutive agonistic Ang-1 release. | Q43202086 |
| | Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche | Q28505006 |
| | RBPjkappa-dependent Notch function regulates Gata2 and is essential for the formation of intra-embryonic hematopoietic cells | Q28511728 |
| | ER71 acts downstream of BMP, Notch, and Wnt signaling in blood and vessel progenitor specification | Q28587231 |
| | A role for Wnt signalling in self-renewal of haematopoietic stem cells | Q28592213 |
| | Notch2 is involved in the overexpression of CD23 in B-cell chronic lymphocytic leukemia | Q28646247 |
| | Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia | Q29614269 |
| | SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells | Q29615006 |
| | Osteoblastic cells regulate the haematopoietic stem cell niche | Q29615007 |
| | Identification of the haematopoietic stem cell niche and control of the niche size | Q29615008 |
| | Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34(+) cells in NOD/SCID mice | Q30165266 |
| | Cis-interactions between Notch and Delta generate mutually exclusive signalling states | Q30494896 |
| | Proteasome inhibition reduces donor-specific antibody levels | Q33383491 |
| | Aberrant expression of Notch signaling molecules in patients with immune thrombocytopenic purpura | Q33385380 |
| | NOTCH1/FBXW7 mutation identifies a large subgroup with favorable outcome in adult T-cell acute lymphoblastic leukemia (T-ALL): a Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL) study | Q33395926 |
| | Characterization of Notch1 antibodies that inhibit signaling of both normal and mutated Notch1 receptors | Q33531734 |
| | Notch-mediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitution | Q33642298 |
| | Acute myelogenous leukemia blasts as accessory cells during T lymphocyte activation: possible implications for future therapeutic strategies | Q33713476 |
| | Impact of interactions of cellular components of the bone marrow microenvironment on hematopoietic stem and progenitor cell function | Q33806045 |
| | Cortical neural precursors inhibit their own differentiation via N-cadherin maintenance of beta-catenin signaling. | Q33834694 |
| | Endothelial cells are essential for the self-renewal and repopulation of Notch-dependent hematopoietic stem cells | Q33837223 |
| | Hemgn is a direct transcriptional target of HOXB4 and induces expansion of murine myeloid progenitor cells | Q34052587 |
| | Downstream targets of HOXB4 in a cell line model of primitive hematopoietic progenitor cells | Q34052591 |
| | Instructive role of the vascular niche in promoting tumour growth and tissue repair by angiocrine factors | Q34152009 |
| | Mammalian numb proteins promote Notch1 receptor ubiquitination and degradation of the Notch1 intracellular domain | Q34189079 |
| | Glycosylation regulates Notch signalling. | Q34271410 |
| | Hematopoiesis is severely altered in mice with an induced osteoblast deficiency | Q34290169 |
| | The nervous system and innate immunity: the neuropeptide connection | Q34420533 |
| | Biological treatment in acute myelogenous leukaemia: how should T-cell targeting immunotherapy be combined with intensive chemotherapy? | Q34452706 |
| | TGFbeta/BMP inhibits the bone marrow transformation capability of Hoxa9 by repressing its DNA-binding ability | Q34545421 |
| | NOTCH1 pathway activation is an early hallmark of SCL T leukemogenesis | Q34663148 |
| | Notch signaling and the bone marrow hematopoietic stem cell niche | Q34776145 |
| | Engraftment and reconstitution of hematopoiesis is dependent on VEGFR2-mediated regeneration of sinusoidal endothelial cells | Q34957840 |
| | c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia/lymphoma | Q34958884 |
| | Notch regulates cytolytic effector function in CD8+ T cells. | Q35219642 |
| | Timely reconstitution of immune competence affects clinical outcome following autologous stem cell transplantation | Q36021089 |
| | Immune reconstitution following hematopoietic progenitor cell transplantation: challenges for the future | Q36090218 |
| | Distinct gene expression profiles of acute myeloid/T-lymphoid leukemia with silenced CEBPA and mutations in NOTCH1. | Q36141686 |
| | The bone marrow vascular niche: home of HSC differentiation and mobilization | Q36262585 |
| | Separation of Notch1 promoted lineage commitment and expansion/transformation in developing T cells | Q36369337 |
| | Use of systemic proteasome inhibition as an immune-modulating agent in disease | Q36754730 |
| | Autoimmunity following haematopoietic stem-cell transplantation | Q36797795 |
| | Immune reconstitution after allogeneic stem cell transplantation with reduced-intensity conditioning regimens | Q36831660 |
| | Notch1 and TGFbeta1 cooperatively regulate Foxp3 expression and the maintenance of peripheral regulatory T cells | Q36843721 |
| | Jagged2 acts as a Delta-like Notch ligand during early hematopoietic cell fate decisions | Q36905544 |
| | Delta-like 4 is the essential, nonredundant ligand for Notch1 during thymic T cell lineage commitment. | Q36946535 |
| | Signaling pathways governing stem-cell fate | Q36959565 |
| | Immunomodulation by mesenchymal stem cells and clinical experience | Q36975987 |
| | Canonical notch signaling is dispensable for the maintenance of adult hematopoietic stem cells | Q37029646 |
| | Dimorphic effects of Notch signaling in bone homeostasis. | Q37165102 |
| | Chronic GVHD as an autoimmune disease | Q37173483 |
| | Notch signaling and diseases: an evolutionary journey from a simple beginning to complex outcomes. | Q37215630 |
| | Reconstitution of the immune system after hematopoietic stem cell transplantation in humans. | Q37307638 |
| | Progression of pancreatic adenocarcinoma is significantly impeded with a combination of vaccine and COX-2 inhibition. | Q37338140 |
| | Notch signaling maintains bone marrow mesenchymal progenitors by suppressing osteoblast differentiation | Q37339719 |
| | Transmission and expansion of HOXB4-induced leukemia in two immunosuppressed dogs: implications for a new canine leukemia model | Q37357517 |
| | The different faces of Notch in T-helper-cell differentiation | Q37376021 |
| | FLT3 inhibition and mechanisms of drug resistance in mutant FLT3-positive AML. | Q37495206 |
| | Mesenchymal stem cells for treatment and prevention of graft-versus-host disease after allogeneic hematopoietic cell transplantation | Q37509139 |
| | Proteasome inhibition for antibody-mediated rejection | Q37577254 |
| | Complexity of CEBPA dysregulation in human acute myeloid leukemia | Q37586686 |
| | Notch signaling in the hematopoietic system | Q37594765 |
| | Acute graft-versus-host disease: new treatment strategies | Q37610714 |
| | c-Myc controls the balance between hematopoietic stem cell self-renewal and differentiation | Q37620912 |
| | Wnt signaling in hematopoiesis: crucial factors for self-renewal, proliferation, and cell fate decisions | Q37673086 |
| | Nuclear factor-kappaB signaling: a contributor in leukemogenesis and a target for pharmacological intervention in human acute myelogenous leukemia | Q37688185 |
| | Novel roles for Notch, Wnt and Hedgehog in hematopoesis derived from human pluripotent stem cells | Q37718709 |
| | The chemokine system in experimental and clinical hematology | Q37724710 |
| | CXCR4 in clinical hematology | Q37732036 |
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P304 | page(s) | 570796 | |
| P577 | publication date | 2010-10-04 | |
| P1433 | published in | Bone Marrow Research | Q26842195 |
| P1476 | title | Future perspectives: therapeutic targeting of notch signalling may become a strategy in patients receiving stem cell transplantation for hematologic malignancies | |
| P478 | volume | 2011 | |